Mucinous adenocarcinoma of the lung is a subtype of highly invasive pulmonary tumors and is associated with decreased or absent expression of the transcription factor NK2 homeobox 1 (NKX2-1; also known as TTF-1). Here, we show that haploinsufficiency of Nkx2-1 in combination with oncogenic KrasG12D, but not with oncogenic EGFRL858R, caused pulmonary tumors in transgenic mice that were phenotypically similar to human mucinous adenocarcinomas. Gene expression patterns distinguished tumor goblet (mucous) cells from nontumorigenic airway and intestinal goblet cells. Expression of NKX2-1 inhibited urethane and oncogenic KrasG12D-induced tumorigenesis in vivo. Haploinsufficiency of Nkx2-1 enhanced KrasG12D-mediated tumor progression, but reduced EGFRL858R-mediated progression. Genome-wide analysis of gene expression demonstrated that a set of genes induced in mucinous tumors was shared with genes induced in a nontumorigenic chronic lung disease, while a distinct subset of genes was specific to mucinous tumors. ChIP with massively parallel DNA sequencing identified a direct association of NKX2-1 with the genes induced in mucinous tumors. NKX2-1 associated with the AP-1 binding element as well as the canonical NKX2-1 binding element. NKX2-1 inhibited both AP-1 activity and tumor colony formation in vitro. These data demonstrate that NKX2-1 functions in a context-dependent manner in lung tumorigenesis and inhibits KrasG12D-driven mucinous pulmonary adenocarcinoma.
Yutaka Maeda, Tomoshi Tsuchiya, Haiping Hao, David H. Tompkins, Yan Xu, Michael L. Mucenski, Lingling Du, Angela R. Keiser, Takuya Fukazawa, Yoshio Naomoto, Takeshi Nagayasu, Jeffrey A. Whitsett
Title and authors | Publication | Year |
---|---|---|
Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations
Han J, Gao J, Chen D, Du M, Wu Y, Ma X, Xie M, Han H, Wu C, Xue X |
The Clinical Respiratory Journal | 2024 |
Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma.
Iwai M, Yokota E, Ishida Y, Yukawa T, Naomoto Y, Monobe Y, Haisa M, Takigawa N, Fukazawa T, Yamatsuji T |
Human Cell | 2024 |
Radiomics and Clinical Characters Based Gaussian Naive Bayes (GNB) Model for Preoperative Differentiation of Pulmonary Pure Invasive Mucinous Adenocarcinoma From Mixed Mucinous Adenocarcinoma
Zhang J, Hao L, Xu Q, Gao F |
Technology in cancer research & treatment | 2024 |
Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLC
Sisoudiya SD, Houle AA, Fernando T, Wilson TR, Schutzman JL, Lee J, Schrock A, Sokol ES, Sivakumar S, Shi Z, Pathria G |
npj Precision Oncology | 2024 |
Nomogram model for the diagnosis of solitary nodular pulmonary mucinous adenocarcinoma
Zhong F, Wu L, Liu Z, Li W, Zhao S |
Scientific Reports | 2024 |
HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non–small cell lung cancer
Eichner LJ, Curtis SD, Brun SN, McGuire CK, Gushterova I, Baumgart JT, Trefts E, Ross DS, Rymoff TJ, Shaw RJ |
Science Advances | 2023 |
TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study.
Katayama Y, Yamada T, Morimoto K, Fujii H, Morita S, Tanimura K, Takeda T, Okada A, Shiotsu S, Chihara Y, Hiranuma O, Yamada T, Ota T, Harada T, Hasegawa I, Yoshimura A, Iwasaku M, Tokuda S, Kim YH, Takayama K |
2023 | |
FOXA2 cooperates with mutant KRAS to drive invasive mucinous adenocarcinoma of the lung
Tomoshige K, Stuart WD, Fink-Baldauf IM, Ito M, Tsuchiya T, Nagayasu T, Yamatsuji T, Okada M, Fukazawa T, Guo M, Maeda Y |
Cancer research | 2023 |
KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming.
Juul NH, Yoon JK, Martinez MC, Rishi N, Kazadaeva YI, Morri M, Neff NF, Trope WL, Shrager JB, Sinha R, Desai TJ |
Nature | 2023 |
Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung adenocarcinomas
Reyes-Castro RA, Chen SY, Seemann J, Kundu ST, Gibbons DL, Arur S |
Science Advances | 2023 |
Tissue specificity of oncogenic BRAF targeted to lung and thyroid through a shared lineage factor.
Schoultz E, Liang S, Carlsson T, Filges S, Ståhlberg A, Fagman H, Wiel C, Sayin V, Nilsson M |
iScience | 2023 |
Dosage amplification dictates oncogenic regulation by the NKX2-1 lineage factor in lung adenocarcinoma
Pulice JL, Meyerson M |
2023 | |
USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity.
Kwon J, Zhang J, Mok B, Allsup S, Kim C, Toretsky J, Han C |
Molecular Cancer | 2023 |
Alveolar epithelial progenitor cells require Nkx2-1 to maintain progenitor-specific epigenomic state during lung homeostasis and regeneration.
Toth A, Kannan P, Snowball J, Kofron M, Wayman JA, Bridges JP, Miraldi ER, Swarr D, Zacharias WJ |
Nature Communications | 2023 |
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review
G Stella, V DAgnano, D Piloni, L Saracino, S Lettieri, F Mariani, A Lancia, C Bortolotto, P Rinaldi, F Falanga, C Primiceri, A Corsico, A Bianco |
Translational Lung Cancer Research | 2022 |
Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity
P Murthy, , D Arguijo, J Everitt, D Kocak, Y Kobayashi, A Bozec, S Vicent, S Ding, G Crawford, D Hsu, P Tata, T Reddy, X Shen |
Developmental Cell | 2022 |
MUC6 expression is a preferable prognostic marker for invasive mucinous adenocarcinoma of the lung
K Yamanoi, C Fujii, H Yuzuriha, M Kumazawa, M Shimoda, K Emoto, H Asamura, J Nakayama |
Histochemistry and Cell Biology | 2022 |
The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RET
Kong Y, Allison DB, Zhang Q, He D, Li Y, Mao F, Li C, Li Z, Zhang Y, Wang J, Wang C, Brainson CF, Liu X |
Science signaling | 2022 |
Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis
Kwon M, Rubio G, Wang H, Riedlinger G, Adem A, Zhong H, Slegowski D, Post-Zwicker L, Chidananda A, Schrump DS, Pine SR, Libutti SK |
2022 | |
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer
Ricciuti B, Alessi JV, Elkrief A, Wang X, Cortellini A, Li YY, Vaz VR, Gupta H, Pecci F, Barrichello A, Lamberti G, Nguyen T, Lindsay J, Sharma B, Felt K, Rodig SJ, Nishino M, Sholl LM, Barbie DA, Negrao MV, Zhang J, Cherniack AD, Heymach JV, Meyerson M, Ambrogio C, Jänne PA, Arbour KC, Pinato DJ, Skoulidis F, Schoenfeld AJ, Awad MM, Luo J |
2022 | |
Nanog maintains stemness of Lkb1 ‐deficient lung adenocarcinoma and prevents gastric differentiation
X Tong, Y Chen, X Zhu, Y Ye, Y Xue, R Wang, Y Gao, W Zhang, W Gao, L Xiao, H Chen, P Zhang, H Ji |
EMBO Molecular Medicine | 2021 |
Differential chromatin binding of the lung lineage transcription factor NKX2-1 resolves opposing murine alveolar cell fates in vivo
DR Little, AM Lynch, Y Yan, H Akiyama, S Kimura, J Chen |
Nature Communications | 2021 |
An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma
R Zewdu, EM Mehrabad, K Ingram, P Fang, KL Gillis, SA Camolotto, G Orstad, A Jones, MC Mendoza, BT Spike, EL Snyder |
eLife | 2021 |
CRISPRi-mediated functional analysis of NKX2-1-binding sites in the lung
WD Stuart, IM Fink-Baldauf, K Tomoshige, M Guo, Y Maeda |
2021 | |
Epithelial cell plasticity: breaking boundaries and changing landscapes
A Tata, RD Chow, PR Tata |
EMBO reports | 2021 |
Transcription start site‐level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance
K Sano, T Hayashi, Y Suehara, M Hosoya, K Takamochi, S Kohsaka, S Kishikawa, M Kishi, S Saito, F Takahashi, K Kaneko, K Suzuki, T Yao, M Ishijima, T Saito |
The Journal of Pathology: Clinical Research | 2021 |
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung
D Ueda, M Ito, Y Tsutani, A Giménez-Capitán, R Román-Lladó, A Pérez-Rosado, C Aguado, K Kushitani, Y Miyata, K Arihiro, MA Molina-Vila, R Rosell, Y Takeshima, M Okada |
Journal of Cancer Research and Clinical Oncology | 2021 |
Loss of Aryl Hydrocarbon Receptor Favors K-RasG12D-Driven Non-Small Cell Lung Cancer
A Nacarino-Palma, CM Rejano-Gordillo, FJ González-Rico, A Ordiales-Talavero, ÁC Román, M Cuadrado, XR Bustelo, JM Merino, PM Fernández-Salguero |
Cancers | 2021 |
Loss of cellular identity in common pre-clinical models of serine‑threonine kinase 11 (Liver kinase B1) loss
SK Karthikeyan, NT Gimbrone, TR Percy, WD Cress |
Cancer Treatment and Research Communications | 2021 |
NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity
K Ingram, SC Samson, R Zewdu, RG Zitnay, EL Snyder, MC Mendoza |
Oncogene | 2021 |
Thyroid Transcription Factor-1: Structure, Expression, Function and Its Relationship with Disease
L Guan, X Zhao, L Tang, J Chen, J Zhao, M Guo, C Chen, Y Zhou, L Xu, I Castellano |
BioMed Research International | 2021 |
NKX2-1 re-expression induces cell death through apoptosis and necrosis in dedifferentiated thyroid carcinoma cells
Y Ito, F Furuya, K Taki, H Suzuki, H Shimura, IV Lebedeva |
PloS one | 2021 |
Differential Regulation of Human Surfactant Protein A Genes, SFTPA1 and SFTPA2, and Their Corresponding Variants
J Floros, N Tsotakos |
Frontiers in immunology | 2021 |
A novel nomogram to predict the overall survival of patients with colloid adenocarcinoma of the lung
J Zhang, D Liu |
Translational cancer research | 2021 |
Chemotherapy in combination with pembrolizumab and antiangiogenesis in young patients with advanced primary pulmonary mucinous adenocarcinoma: Two case reports
Zhou D, Gulinuer W, Zhu N |
Science Progress | 2021 |
Reciprocal expression of trefoil factor‐1 and thyroid transcription factor‐1 in lung adenocarcinomas
D Matsubara, T Yoshimoto, M Soda, Y Amano, A Kihara, T Funaki, T Ito, Y Sakuma, T Shibano, S Endo, K Hagiwara, S Ishikawa, M Fukayama, Y Murakami, H Mano, T Niki |
Cancer Science | 2020 |
Long noncoding RNA HOXC-AS3 facilitates the progression of invasive mucinous adenocarcinomas of the lung via modulating FUS/FOXM1
Z Yang, T Hu |
In vitro cellular & developmental biology. Animal | 2020 |
CRISPRi-mediated functional analysis of lung disease-associated loci at non-coding regions
WD Stuart, M Guo, IM Fink-Baldauf, AM Coleman, JP Clancy, MA Mall, FY Lim, JJ Brewington, Y Maeda |
2020 | |
Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma
S Kishikawa, T Hayashi, T Saito, K Takamochi, S Kohsaka, K Sano, N Sasahara, K Sasa, T Kurihara, K Hara, Y Suehara, F Takahashi, K Suzuki, T Yao |
Modern Pathology | 2020 |
The prognostic effect of TTF-1 expression in the Chinese population of patients with advanced lung adenocarcinomas
X Li, L Yin, Y Zhao, M He, Q Qi, Y Sun, H Li, M Evison |
Translational Lung Cancer Research | 2020 |
Mutationally-activated PI3’-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase
JE van Veen, M Scherzer, J Boshuizen, M Chu, A Liu, A Landman, S Green, C Trejo, M McMahon |
eLife | 2019 |
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
F Skoulidis, JV Heymach |
Nature Reviews Cancer | 2019 |
Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells
O DAlmeida, O Mothar, EA Bondzie, Y Lieumo, L Tagne, S Gupta, T Volkert, S Levine, JB Tagne |
BMC Cancer | 2019 |
Molecular and Morphological Profiling of Lung Cancer: A Foundation for “Next-Generation” Pathologists and Oncologists
J Kashima, R Kitadai, Y Okuma |
Cancers | 2019 |
Mechanistic Study of TTF-1 Modulation of Cellular Sensitivity to Cisplatin
CA Phelps, L Lindsey-Boltz, A Sancar, D Mu |
Scientific Reports | 2019 |
Transcriptional control of lung alveolar type 1 cell development and maintenance by NK homeobox 2-1
DR Little, KN Gerner-Mauro, P Flodby, ED Crandall, Z Borok, H Akiyama, S Kimura, EJ Ostrin, J Chen |
Proceedings of the National Academy of Sciences | 2019 |
ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression
Q Ma, K Wu, H Li, H Li, Y Zhu, G Hu, L Hu, X Kong |
Scientific Reports | 2019 |
Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer
S Hokari, Y Tamura, A Kaneda, A Katsura, M Morikawa, F Murai, S Ehata, S Tsutsumi, Y Ishikawa, H Aburatani, T Kikuchi, K Miyazono, D Koinuma |
Molecular Oncology | 2019 |
Requirement for MUC5AC in K-RAS dependent lung carcinogenesis
Alison K. Bauer, Misha Umer, Vanessa L Richardson, Amber M Cumpian, Anna Q. Harder, Nasim Khosravi, Zoulikha Azzegagh, Naoko Hara, Camille Ehre, Maedeh Mohebnasab, Mauricio S. Caetano, daniel t merrick, Adrie van Bokhoven, Ignacio Wistuba, Humam Kadara, Burton F Dickey, Kalpana Velmurugan, Patrick R Mann, Xian Lu, Anna Baron, Christopher M. Evans, Seyed Javad Moghaddam |
JCI Insight | 2018 |
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma
DR Caswell, CH Chuang, RK Ma, IP Winters, EL Snyder, MM Winslow |
Molecular cancer research : MCR | 2018 |
Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancer
RA Jones, SE Franks, RA Moorehead, A Ahmad |
PloS one | 2018 |
An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo
K Tomoshige, M Guo, T Tsuchiya, T Fukazawa, IM Fink-Baldauf, WD Stuart, Y Naomoto, T Nagayasu, Y Maeda |
Oncogene | 2018 |
Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism
SC Lai, CA Phelps, AM Short, SM Dutta, D Mu |
Oncogene | 2018 |
Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity
PR Tata, RD Chow, SV Saladi, A Tata, A Konkimalla, A Bara, D Montoro, LP Hariri, AR Shih, M Mino-Kenudson, H Mou, S Kimura, LW Ellisen, J Rajagopal |
Developmental Cell | 2018 |
Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas
T Sumi, S Hirai, M Yamaguchi, Y Tanaka, M Tada, Yamada, T Hasegawa, Y Miyagi, T Niki, A Watanabe, H Takahashi, Y Sakuma |
International journal of oncology | 2018 |
NKX2-1-AS1 negatively regulates CD274/PD-L1, cell-cell interaction genes, and limits human lung carcinoma cell migration
H Kathuria, G Millien, L McNally, AC Gower, JB Tagne, Y Cao, MI Ramirez |
Scientific Reports | 2018 |
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment
G Mollaoglu, A Jones, SJ Wait, A Mukhopadhyay, S Jeong, R Arya, SA Camolotto, TL Mosbruger, CJ Stubben, CJ Conley, A Bhutkar, JM Vahrenkamp, KC Berrett, MH Cessna, TE Lane, BL Witt, ME Salama, J Gertz, KB Jones, EL Snyder, TG Oliver |
Immunity | 2018 |
Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3
T Nakagomi, T Goto, Y Hirotsu, D Shikata, Y Yokoyama, R Higuchi, S Otake, K Amemiya, T Oyama, H Mochizuki, M Omata |
Cancers | 2018 |
Gene signature driving invasive mucinous adenocarcinoma of the lung
M Guo, K Tomoshige, M Meister, T Muley, T Fukazawa, T Tsuchiya, R Karns, A Warth, IM FinkBaldauf, T Nagayasu, Y Naomoto, Y Xu, MA Mall, Y Maeda |
EMBO Molecular Medicine | 2017 |
Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma: Reappraising mucinous and colloid adenocarcinoma of the lung
A Sonzogni, F Bianchi, A Fabbri, M Cossa, G Rossi, A Cavazza, E Tamborini, F Perrone, A Busico, I Capone, B Picciani, B Valeri, U Pastorino, G Pelosi |
The Journal of Pathology: Clinical Research | 2017 |
FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas
D Milewski, D Balli, V Ustiyan, T Le, H Dienemann, A Warth, K Breuhahn, JA Whitsett, VV Kalinichenko, TV Kalin, KW Hunter |
PLoS genetics | 2017 |
TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas
Z Liu, K Yanagisawa, S Griesing, M Iwai, K Kano, N Hotta, T Kajino, M Suzuki, T Takahashi |
Oncogene | 2017 |
Characterization of V-set and immunoglobulin domain containing 1 exerting a tumor suppressor function in gastric, lung, and esophageal cancer cells
Y Inoue, S Matsuura, K Yoshimura, Y Iwashita, T Kahyo, A Kawase, M Tanahashi, M Maeda, H Ogawa, N Inui, K Funai, K Shinmura, H Niwa, T Suda, H Sugimura |
Cancer Science | 2017 |
Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas
D Matsubara, M Soda, T Yoshimoto, Y Amano, Y Sakuma, A Yamato, T Ueno, S Kojima, T Shibano, Y Hosono, M Kawazu, Y Yamashita, S Endo, K Hagiwara, M Fukayama, T Takahashi, H Mano, T Niki |
Cancer Science | 2017 |
Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells
S Griesing, T Kajino, MC Tai, Z Liu, M Nakatochi, Y Shimada, M Suzuki, T Takahashi |
Cancer Science | 2017 |
The role of Thyroid Transcription Factor-1 and Tumor differentiation in Resected Lung Adenocarcinoma
TW Huang, KF Lin, CH Lee, H Chang, SC Lee, YS Shieh |
Scientific Reports | 2017 |
Biology of invasive mucinous adenocarcinoma of the lung
YJ Cha, HS Shim |
Translational Lung Cancer Research | 2017 |
NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer
J Moisés, A Navarro, S Santasusagna, N Viñolas, L Molins, J Ramirez, J Osorio, A Saco, JJ Castellano, C Muñoz, S Morales, M Monzó, RM Marrades |
BMC Pulmonary Medicine | 2017 |
Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas
JB Schilsky, A Ni, L Ahn, S Datta, WD Travis, MG Kris, JE Chaft, N Rekhtman, MD Hellmann |
Lung cancer (Amsterdam, Netherlands) | 2017 |
Roles of Thyroid Transcription Factor 1 in Lung Cancer Biology.
Phelps CA, Lai SC, Mu D |
Vitamins and hormones | 2017 |
Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome
LW Wood, NI Cox, CA Phelps, SC Lai, A Poddar, C Talbot, D Mu |
Scientific Reports | 2016 |
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
T Fukazawa, M Guo, N Ishida, T Yamatsuji, M Takaoka, E Yokota, M Haisa, N Miyake, T Ikeda, T Okui, N Takigawa, Y Maeda, Y Naomoto |
Scientific Reports | 2016 |
Lung Cancer with Diffuse Ground-glass Shadow in Two Lungs and Respiratory Failure
ZM Feng, ZJ Zhuang, WB He, JP Ding, WJ Yang, XY Chen |
Chinese Medical Journal | 2016 |
Lineage factors and differentiation states in lung cancer progression
WK Cheung, DX Nguyen |
Oncogene | 2015 |
Development and plasticity of alveolar type 1 cells
J Yang, BJ Hernandez, DM Alanis, O Narvaez, L Vila-Ellis, H Akiyama, SE Evans, EJ Ostrin, J Chen |
Development (Cambridge, England) | 2015 |
ERBB3-Independent Activation of the PI3K Pathway in EGFR-Mutant Lung Adenocarcinomas
X Song, PD Fan, A Bantikassegn, U Guha, DW Threadgill, H Varmus, K Politi |
Cancer research | 2015 |
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, C Behrens, H Kadara, ER Parra, JR Canales, J Zhang, U Giri, J Gudikote, MA Cortez, C Yang, Y Fan, M Peyton, L Girard, KR Coombes, C Toniatti, TP Heffernan, M Choi, GM Frampton, V Miller, JN Weinstein, RS Herbst, KK Wong, J Zhang, P Sharma, GB Mills, WK Hong, JD Minna, JP Allison, A Futreal, J Wang, II Wistuba, JV Heymach |
Cancer Discovery | 2015 |
SINCERA: A Pipeline for Single-Cell RNA-Seq Profiling Analysis
M Guo, H Wang, SS Potter, JA Whitsett, Y Xu, A Prlic |
PLoS computational biology | 2015 |
Keeping it together: Pulmonary alveoli are maintained by a hierarchy of cellular programs
CY Logan, TJ Desai |
BioEssays | 2015 |
Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb
JB Tagne, OR Mohtar, JD Campbell, M Lakshminarayanan, J Huang, AC Hinds, J Lu, MI Ramirez |
Respiratory Research | 2015 |
How do K-RAS-activated cells evade cellular defense mechanisms?
YS Lee, SC Bae |
Oncogene | 2015 |
Alveolar Development and Disease
JA Whitsett, TE Weaver |
American journal of respiratory cell and molecular biology | 2015 |
Lung Cancer in the Era of Precision Medicine
K Politi, RS Herbst |
Clinical cancer research | 2015 |
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B
K Wakata, T Tsuchiya, K Tomoshige, K Takagi, N Yamasaki, K Matsumoto, T Miyazaki, A Nanashima, JA Whitsett, Y Maeda, T Nagayasu |
BMJ Open | 2015 |
PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression
J Jendrzejewski, A Thomas, S Liyanarachchi, A Eiterman, J Tomsic, H He, HS Radomska, W Li, R Nagy, K Sworczak, A la Chapelle |
The Journal of clinical endocrinology and metabolism | 2015 |
Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer
N Clarke, J Biscocho, KA Kwei, JM Davidson, S Sridhar, X Gong, JR Pollack, JT Chi |
PloS one | 2015 |
NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
Chen PM, Wu TC, Cheng YW, Chen CY, Lee H |
Oncotarget | 2015 |
Proceedings of the 2014 National Toxicology Program Satellite Symposium
SA Elmore, MC Cora, MM Gruebbel, SA Hayes, JS Hoane, H Koizumi, R Peters, TJ Rosol, BP Singh, KA Szabo |
Toxicologic pathology | 2014 |
Pulmonary macrophage transplantation therapy
T Suzuki, P Arumugam, T Sakagami, N Lachmann, C Chalk, A Sallese, S Abe, C Trapnell, B Carey, T Moritz, P Malik, C Lutzko, RE Wood, BC Trapnell |
Nature | 2014 |
Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung
Somaiah N, Fidler MJ, Garrett-Mayer E, Wahlquist A, Shirai K, Buckingham L, Hensing T, Bonomi P, Simon GR |
Oncoscience | 2014 |
MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1)
SJ Rice, SC Lai, LW Wood, KR Helsley, EA Runkle, MM Winslow, D Mu |
The Journal of biological chemistry | 2013 |
The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities
D Mu |
The Journal of biological chemistry | 2013 |
Tight junction proteins: From barrier to tumorigenesis
EA Runkle, D Mu |
Cancer Letters | 2013 |
Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target
H Watanabe, JM Francis, MS Woo, B Etemad, W Lin, DF Fries, S Peng, EL Snyder, PR Tata, F Izzo, AC Schinzel, J Cho, PS Hammerman, RG Verhaak, WC Hahn, J Rajagopal, T Jacks, M Meyerson |
Genes & development | 2013 |
Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma
EL Snyder, H Watanabe, M Magendantz, S Hoersch, TA Chen, DG Wang, D Crowley, CA Whittaker, M Meyerson, S Kimura, T Jacks |
Molecular Cell | 2013 |
Control of Alveolar Differentiation by the Lineage Transcription Factors GATA6 and HOPX Inhibits Lung Adenocarcinoma Metastasis
WK Cheung, M Zhao, Z Liu, LE Stevens, PD Cao, JE Fang, TF Westbrook, DX Nguyen |
Cancer Cell | 2013 |
Hopping between Differentiation States in Lung Adenocarcinoma
H Watanabe, M Meyerson |
Cancer Cell | 2013 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |